Summary
A wide variety of drugs may be associated with serious cardiovascular toxicity. Toxicity due to drugs primarily used for treating cardiac disorders is the most extensively documented, especially the arrhythmias due to digitalis glycosides. Various arrhythmias are also caused by toxic levels of many antiarrhythmic agents including quinidine, procainamide and phenytoin. Myocardial depression and heart failure are serious side-effects of β-adrenoceptor blocking agents and myocardial ischaemia due to sympathomimetic amines may result from both direct and indirect mechanisms. p]The many toxic reactions in the cardiovascular system due to non-cardiac drugs are less widely known and for the most part less clearly understood. Many remain controversial at the current time; for example, the diathesis toward thromboembolism in women taking oral contraceptives. p]Potential cardiac toxicity due to drugs used in the rapidly expanding sphere of anti-neoplastic chemotherapy is exemplified by the cardiomyopathy-like toxicities of doxorubicin and daunorubicin. Many of the Psychotherapeutic drugs including phenothiazine antipsychotics and tricyclic antidepressants have arrhythmogenic potential.
Similar content being viewed by others
References
Alderman, E.L.; Barry, W.H.; Graham, A.F. and Harrison, D.C.: Hemodynamic effects of morphine and pentazocine in cardiac patients. New England Journal of Medicine 287: 623–627 (1972).
Alexander, C.S. and Nino, A.: Cardiovascular complications in young patients taking psychotropic drugs. American Heart Journal 78: 757–769(1969).
Anon.: Adriamycin and the heart. Lancet 1: 1325 (1974).
Bailar, J.C.: Thromboembolism and estrogen therapy. Lancet 2: 560(1969).
Bana, D.S.; MacNeal, P.S.; Le Compte, P.M.; Shah, Y. and Graham, J.R.: Cardiac murmurs and endocardial fibrosis associated with methysergide therapy. American Heart Journal 88: 640–655 (1974).
Beller, G.A.; Smith, T.W.; Abelman, W.H.; Haber, E. and Hood, W.B. Jr.: Digitalis intoxication. A prospective clinical study with serum level correlations. New England Journal of Medicine 284: 989–997 (1971).
Blum, R.H. and Carter, S.K.: Adriamycin: A new anticancer drug with significant clinical activity. Annals of Internal Medicine 80: 249–259(1974).
Breidahl, H.D.; Ennis, G.C.; Martin, F.R.; Stawell, J.R. and Taft, P.: Insulin and oral hypoglycemic agents. I: Physiological and clinical pharmacological aspects. Drugs 3: 79–107; 204-226 (1972).
Bryan, C.K.; Ludy, J.A.; Hak, S.H.; Roberts, R. and Marshall, W.K.: Overdose with tricyclic antidepressants. Drug Intelligence and Clinical Pharmacy 10: 380–384 (1976).
Buckner, C.D.; Rudolf, R.H.; Fefer, A.; Clift, A.; Epstein, R.B.; Funk, D.D.; Neiman, P.E.; Slichter, S.J.; Storb, R. and Thomas, E.D.: High dose cyclophosphamide therapy for malignant disease. Cancer 29: 357–365 (1972).
Buja, C.M.; Farrans, V.J.; Mayer, R.J.; Roberts, W.L. and Henderson, E.S.: Cardiac ultrastructural changes induced by daunorubicin therapy. Cancer 32: 771–778 (1973).
Byar, D.P.: Treatment of prostatic cancer: studies by the Veterans Administration Cooperative Research Group. Bulletin of the New York Academy of Medicine 48: 751–776 (1972).
Cabizuca, S.V. and Desser, K.B.: Carbenicillin associated hypokalemic alkalosis. Journal of the American Medical Association 235: 956–957(1976).
Chung, E.K.: Digitalis Intoxication (Excerpta Medica, Amsterdam 1969).
Condemi, J.J.; Blomgren, W.E. and Vaughan, J.H.: The procainamide induced lupus syndrome. Bulletin on the Rheumatic Diseases 20: 604–608 (1970).
Coull, D.C.; Dingwall-Fardyce, I.; Crooks, J. and Scott, A.M.: Amytriptyline and cardiac disease. Lancet 2: 590–591 (1970).
Crane, G.E.: Cardiac toxicity and psychotropic drugs. Diseases of the Nervous System 31: 534–539 (1971).
Deglin, S.M.; Deglin, J.N. and Chung, E.K.: Direct current shock and digitalis glycosides. In press (1976).
Demers, R.G. and Henniger, G.R.: Electrocardiographic T wave changes during lithium carbonate treatment. Journal of the American Medical Association 218: 381–386 (1971).
Fowler, N.O.; McCall, D.; Chou, T.C.; Holmes, J.C. and Hanenson, I.B.: Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. American Journal of Cardiology 37: 223–230 (1976).
Frolich, E.D.; Taraza, R.C. and Dustan, H.P.: Peripheral arterial insufficiency. Journal of the American Medical Association 208: 2471–2472(1969).
Gilladoga, A.C.; Tan, C.; Wollair, N.; Murphy, M.L. and Sternberg, S.: Adriamycin cardiomyopathy: Diagnosis and management, case reports. Proceedings of the American Association of Cancer Research 14: 95 (1973).
Gladstone, G.R.; Hordof, A. and Gersony, W.M.: Propranolol administration during pregnancy: Effects on the fetus. Journal of Pediatrics 86:962(1975).
Greenblatt, D.J. and Koch-Weser, J.: Adverse reactions to propranolol in hospitalised patients. American Heart Journal 86: 478–484(1973).
Haft, J.I.: Cardiovascular injury induced by sympathetic catecholamines. Progress in Cardiovascular Diseases 17: 73–86(1974).
Hollister, L.E. and Kosek, J.C.: Sudden death during treatment with phenothiazine derivatives. Journal of the American Medical Association 192: 1035–1038 (1965).
Hougie, C.: Thromboembolism and oral contraceptives. American Heart Journal 85: 538–545 (1973).
Inman, W.H.W. and Vessey, M.P.: Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child bearing age. British Medical Journal 2: 193–199(1968).
Jarvik, M.E.: Drugs in the treatment of psychiatric disorders; In Goodman and Gilman (Eds) The Pharmacological Basis of Therapeutics, 4th Ed, p. 162 (Macmillan, New York 1970).
Jefferson, J.W.: A review of the cardiovascular effects and toxicity of tricyclic antidepressants. Psychosomatic Medicine 37: 160–179(1975).
Jelliffe, R. and Brooker, G.: A nomogram for digoxin therapy. American Journal of Medicine 57: 63–68 (1974).
Jones, S.; Ewy, G. and Grooves, B.: Echocardiographic detection of adriamycin cardiotoxicity. Proceedings of the American Society of Clinical Oncology 16: 228 (1975).
Kanada, S.A.; Kanada, D.J.; Hutchinson, R.A. and Wu, D.: Angina-like syndrome with diazoxide for hypertensive crisis. Annals of Internal Medicine 84: 696–699 (1976).
Kantor, S.; Bigger, J.T.; Glassman, A.H.; Macken, D.L. and Perel, J.M.: Imipramine induced heart block. Journal of the American Medical Association 231: 1364–1366 (1975).
Koch-Weser, J.: Correlation of serum concentrations and pharmacologic effects of antiarrhythmic drugs; In Pharmacology and Future of Man, Proceedings of the 5th International Congress of Pharmacology, vol. 3, p.69 (Karger, Basel 1973).
Koch-Weser, J.: Drug therapy: hydrallazine. New England Journal of Medicine 295: 320–323 (1976).
Lasagna, L.: How useful are serum digitalis measurements? New England Journal of Medicine 294: 898 (1976).
Lawrence, J.R. and Lee, F.R.: Ventricular fibrillation after narcotic withdrawal. Lancet 2: 717 (1975).
Lefrak, E.A.; Pitha, J.; Rosenheim, S. and Gottlieb, J.A.: A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32:302–314(1973).
Leifer, K.N. and Wittig, H.J.: The Beta-2 sympathomimetic aerosols in the treatment of asthma. Annals of Allergy 35: 69–80 (1975).
Lipski, J.; Stimmel, B. and Donoso, E.: The effect of heroin and multiple drug abuse on the electrocardiogram. American Heart Journal 86: 663–668(1973).
Mann, J.I.; Vessey, M.P.; Thorogood, M. and Doll, R.: Myocardial infarction in young women with special reference to oral contraceptive practice. British Medical Journal 2: 241–244 (1975).
Mason, D.T.; Zelis, R.; Lee, G.; Hughes, J.C. and Spann, J.F.: Current concepts and treatment of digitalis toxicity. American Journal of Cardiology 27: 546–558 (1971).
Mercer, C.W. and Logic, J.R.: Cardiac arrest due to hyperkalemia following intravenous penicillin administration. Chest 64: 358–359(1973).
Michaelis, L.L.; Hickey, P.R.; Clark, T.A. and Dixon, W.M.: Ventricular irritability associated with the use of naloxone hydrochloride. Annals of Thoracic Surgery 18: 608–614(1974).
Miller, R.R.; Olson, H.G.; Amsterdam, E.A. and Mason, D.T.: Propranolol withdrawal rebound phenomenon. New England Journal of Medicine 293: 416–418 (1975).
Minow, R.; Gottlieb, J. and Freireich, E.: Electrocardiogram QRS voltage changes in adriamycin cardiomyopathy. Proceedings of the American Society of Clinical Oncology 16: 87 (1975).
Missri, J.: Variant angina and propranolol. New England Journal of Medicine 294: 1007(1976).
Nies, A.S. and Shand, D.G.: Clinical pharmacology of propranolol. Circulation 52: 6–15 (1975).
Pinder, R.M.; Brogden, R.N.; Speight, T.M. and Avery, G.S.: Doxepin up-to-date: A review of its pharmacological properties and therapeutic efficacy with particular reference to depression. Drugs 13: 161–218 (1977).
Rinehart, J.; Lewis, R. and Blacerzak, S.: Adriamycin cardiotoxicity in man. Annals of Internal Medicine 81: 475–478 (1974).
Rosenberg, L.; Armstrong, B. and Jick, H.: Myocardial infarction and estrogen therapy in post-menopausal women. New England Journal of Medicine 294: 1256–1259 (1976).
Simpson, F.O.: β-Adrenergic receptor blocking drugs in hypertension. Drugs 7: 85–105(1974).
Singer, I. and Rotenberg, D.: Mechanisms of lithium action. New England Journal of Medicine 289: 254–260 (1973).
Smith, T.W.: Digitalis glycosides. New England Journal of Medicine 288: 942–946 (1973).
Starb, R.; Thomas, E.D.; Buckber, C.D.; Ceft, R.A.; Johnson, F.L.; Fefer, A.; Glucksberg, H.; Giblett, E.R., Lerner, K.G. and Neiman, P.: Allogenic marrow grafting for treatment of aplastic anaemia. Blood 43: 157–180 (1974).
Stokes, G.S.: Drug-induced hypertension: Pathogenesis and management. Drugs 12: 222–230 (1976).
Surawicz, B. and Lasseter, K.C.: Effect of drugs on the electrocardiogram. Progress in Cardiovascular Diseases 13: 26–55 (1970).
Swedberg, K. and Winblad, B.: Heart failure as a complication of lithium treatment. Acta Medica Scandinavica 196: 279–280 (1974).
Tangedahl, T.N. and Gau, G.T.: Myocardial irritability associated with lithium carbonate therapy. New England Journal of Medicine 287: 867–869(1972).
Tseng, H.L.: Interstitial myocarditis probably related to lithium carbonate intoxication. Archives of Pathology 92: 444–448 (1971).
Ugoretz, R.J.: Cardiac effects of doxorubicin therapy of neoplasma. Journal of the American Medical Association 235: 295–296(1976).
Vacek, V.; Tesarova-Magrova, J. and Stafova, J.: Prevention of adverse reactions in therapy with high doses of lincomycin. Arzneimittel Forschung 20: 99–101 (1970).
Vessey, M.P. and Doll, R.: Investigation of relation between use of oral contraceptives and thromboembolic diseases. British Medical Journal 2: 199–205 (1968).
Vohra, J. and Burrows, G.D.: Cardiovascular complications of tricyclic antidepressant overdosage. Drugs 8: 432–437 (1974).
Waisbren, B.A.: Lincomycin in larger doses. Journal of the American Medical Association 206: 2118 (1968).
Weinberger, M.H.: Oral contraceptives and hypertension. Hospital Practice 10: 65–75 (May 1975).
Wilcox, R.G.; James, P.D. and Toghill, P.J.: Endomyocardial fibrosis associated with daunorubicin therapy. British Heart Journal 38: 860–863(1976).
Williams, R.B. and Sherter, C.: Cardiac complications of tricyclic antidepressant therapy. Annals of Internal Medicine 13: 26–55 (1970).
Wilson, J.R. Kraun, E.S.; Bailas, M.M. and Rakita, L.: Reversible sinus node abnormalities due to lithium carbonate therapy. American Journal of Medicine 59: 285–287 (1975).
Winkle, R.A.; Glantz, S.A. and Harrison, D.C.: The pharmacologic therapy of ventricular arrhythmias. American Journal of Cardiology 36: 629–650 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Deglin, S.M., Deglin, J.M. & Chung, E.K. Drug-Induced Cardiovascular Diseases. Drugs 14, 29–40 (1977). https://doi.org/10.2165/00003495-197714010-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197714010-00002